4'-Methoxy-α-pyrrolidinopropiophenone
From Self-sufficiency
Jump to: navigation, search
250px | |
Systematic (IUPAC) name | |
---|---|
(RS)-1-(4-methoxyphenyl)-2-(1-pyrrolidinyl)-1-propanone | |
Identifiers | |
PubChem | CID 6430836 |
Chemical data | |
Formula | C14H19NO2 |
Molar mass | 233.305 g/mol[[Script error: No such module "String".]] |
Script error: No such module "collapsible list". | |
4'-Methoxy-α-pyrrolidinopropiophenone (MOPPP) is a stimulant drug. It is structurally related to α-PPP in the same way that PMA is related to amphetamine: a methoxy group has been added to the 4-position on the phenyl ring. MOPPP was sold in Germany as a designer drug in the late 1990s and early 2000s,[1][2][3] along with a number of other pyrrolidinophenone derivatives,[4][5] although it has never achieved the same international popularity as its better-known relations α-PPP and MDPV.
See also
- α-Pyrrolidinopropiophenone (α-PPP)
- 4'-Methyl-α-pyrrolidinopropiophenone (MPPP)
- 3,4-Methylenedioxy-α-pyrrolidinopropiophenone (MDPPP)
- 3',4'-Methylenedioxy-α-pyrrolidinobutiophenone (MDPBP)
References
Cite error: Invalid <references>
tag;
parameter "group" is allowed only.
<references />
, or <references group="..." />
| |||||||||||||||||||||
| |||||||||||||||||||||
| |||||||||||||||||||||
| |||||||||||||||||||||
|
This pharmacology-related article is a stub. You can help ssf by expanding it. |
- ↑ Springer D, Fritschi G, Maurer HH. Metabolism and toxicological detection of the new designer drug 4'-methoxy-alpha-pyrrolidinopropiophenone studied in rat urine using gas chromatography-mass spectrometry. Journal of Chromatography B. Analytical Technologies in the Biomedical and Life Sciences. 2003 Aug 15;793(2):331-42. PMID 12906908
- ↑ Springer D, Staack RF, Paul LD, Kraemer T, Maurer HH. Identification of cytochrome P450 enzymes involved in the metabolism of 4'-methoxy-alpha-pyrrolidinopropiophenone (MOPPP), a designer drug, in human liver microsomes. Xenobiotica. 2003 Oct;33(10):989-98. PMID 14555336
- ↑ Springer D, Fritschi G, Maurer HH. Metabolism of the new designer drug alpha-pyrrolidinopropiophenone (PPP) and the toxicological detection of PPP and 4'-methyl-alpha-pyrrolidinopropiophenone (MPPP) studied in rat urine using gas chromatography-mass spectrometry. Journal of Chromatography B. Analytical Technologies in the Biomedical and Life Sciences. 2003 Nov 5;796(2):253-66. PMID 14581066
- ↑ Maurer HH, Kraemer T, Springer D, Staack RF. Chemistry, pharmacology, toxicology, and hepatic metabolism of designer drugs of the amphetamine (ecstasy), piperazine, and pyrrolidinophenone types: a synopsis. Therapeutic Drug Monitoring. 2004 Apr;26(2):127-31. PMID 15228152
- ↑ Staack RF, Maurer HH. Metabolism of designer drugs of abuse. Current Drug Metabolism. 2005 Jun;6(3):259-74. PMID 15975043
Retrieved from "http://ssf.f15ijp.com/wiki/index.php?title=4%27-Methoxy-α-pyrrolidinopropiophenone&oldid=28407"
Categories:
- Pages with script errors
- Pages using duplicate arguments in template calls
- Pages with broken file links
- Infobox drug articles with non-default infobox title
- Infobox drug tracked parameters
- Chemical articles without CAS Registry Number
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugboxes with an unspecified ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Cathinones
- Stimulants
- Pyrrolidinophenones
- Phenol ethers
- Pharmacology stubs
- 2Fix